Business Context and Reporting Period
This Form 8-K is a current report filed by Exicure, Inc. on April 16, 2018, regarding the appointment of a principal officer. The report details the hiring of Matthias G. Schroff, Ph.D., as Chief Operating Officer (COO), effective April 16, 2018.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and appointment terms.
Material Changes
The primary material change is the addition of Dr. Schroff to the executive leadership team. He brings prior experience as CEO of VAXIMM AG (2016-2017) and Mologen AG (2008-2015).
Compensation and Management Commentary
- Base Salary: $275,000 annually, subject to periodic adjustment.
- Performance Bonus: Eligible for up to 25% of base salary, prorated for 2018, based on goals set by the Compensation Committee.
- Equity Grant: Stock option to purchase up to 345,000 shares at fair market value on the grant date.
- Vesting Schedule: 25% vests on the one-year anniversary; the remainder vests monthly (1/48th) thereafter, contingent on continued employment.
- Change in Control: Accelerated vesting applies upon involuntary termination (other than for cause) within 12 months following a change in control.
- Relocation: Company will cover up to $50,000 in relocation expenses.
- Indemnification: Dr. Schroff has entered into the company's standard indemnification agreement.
Investor Verification Checklist
- Verify the final approval of the 345,000 share stock option by the Compensation Committee.
- Review the specific performance goals established for the 2018 bonus calculation.
- Confirm the exercise price of the stock option once the grant date is finalized.
- Check the full text of the Offer Letter filed as an exhibit to the Quarterly Report for the period ended March 31, 2018.